Becker et al. [43] investigated 243 older (≥ 60 years) primary CN-AML patients, and found that WT1-mutated patients (7%) had more frequent FLT3-ITD (p < 0.001) and shorter OS (p = 0.08) compared with WT1-wild-type patients. The gene discussed is WT1; the disease is acute myeloid leukemia.